Ligand Pharmaceuticals Incorporated
LGND
$104.97
$0.350.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.63% | -3.21% | -26.94% | 82.37% | -10.60% |
| Total Receivables | -12.89% | 25.98% | 24.64% | -21.05% | 9.19% |
| Inventory | -15.69% | -10.35% | -12.49% | -10.98% | -5.60% |
| Prepaid Expenses | -- | -- | 54.49% | 4.65% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -30.39% | -6.86% | 453.24% | 77.31% | 26.70% |
| Total Current Assets | 7.17% | -0.92% | -15.36% | 55.38% | -6.52% |
|
|
|||||
| Total Current Assets | 7.17% | -0.92% | -15.36% | 55.38% | -6.52% |
| Net Property, Plant & Equipment | -1.53% | -1.05% | 4.41% | -2.71% | -3.53% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 1.82% | -0.39% |
| Goodwill | 0.00% | 0.00% | 0.00% | 1.82% | -0.39% |
| Total Other Intangibles | -3.00% | -2.92% | -2.83% | -2.73% | -6.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.74% | 78.59% | 65.20% | 6.22% | 327.15% |
| Total Assets | -1.37% | 10.21% | -5.19% | 16.09% | 2.34% |
|
|
|||||
| Total Accounts Payable | 11.48% | 161.80% | -5.28% | -22.00% | -1.94% |
| Total Accrued Expenses | 93.07% | 35.01% | 23.43% | -21.36% | 25.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.35% | -6.68% | 16.45% | 144.63% | -17.51% |
| Total Finance Division Other Current Liabilities | -12.23% | -0.77% | -16.85% | 81.25% | -18.10% |
| Total Other Current Liabilities | -12.23% | -0.77% | -16.85% | 81.25% | -18.10% |
| Total Current Liabilities | 49.81% | 33.43% | 4.19% | 6.17% | 6.71% |
|
|
|||||
| Total Current Liabilities | 49.81% | 33.43% | 4.19% | 6.17% | 6.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.43% | -2.31% | 22.80% | -9.53% | -0.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -17.29% | 24.80% | -21.44% | 32.25% | -20.09% |
| Total Liabilities | -2.07% | 24.65% | -15.04% | 24.39% | -14.83% |
|
|
|||||
| Common Stock & APIC | 9.06% | 29.50% | 9.44% | 9.84% | 7.99% |
| Retained Earnings | -5.86% | -1.33% | -8.81% | 17.12% | 3.75% |
| Treasury Stock & Other | -440.32% | 286.74% | -2.75% | -11.38% | 13.45% |
| Total Common Equity | -1.28% | 8.51% | -3.88% | 15.07% | 4.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.28% | 8.51% | -3.88% | 15.07% | 4.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.28% | 8.51% | -3.88% | 15.07% | 4.94% |
|
|
|||||